An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

This recognition follows another recent honor for Mr. Kras, who was named a finalist for the Entrepreneur Of The Year® 2024 New Jersey Award by Ernst & Young (EY US). This award celebrates innovative ...

Edible Garden CEO Jim Kras recognized in NJBIZ Power 100 for his impact on New Jersey's economy and sustainability efforts. The recognition of CEO Jim Kras may overshadow potential underlying ...

Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will likely be announcing its earnings results before the market opens on ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer. Among patients with heavily pretreated patients with KRAS ...

Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...

The Lung Cancer Research Foundation (LCRF) is pleased to announce its partnership with Israel Cancer Research Fund (ICRF) on ...